BioVie Inc/$BIVI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About BioVie Inc
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
Ticker
$BIVI
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
14
Website
BioVie Inc Metrics
BasicAdvanced
$11M
-
-$16.61
1.11
-
Price and volume
Market cap
$11M
Beta
1.11
52-week high
$9.56
52-week low
$6.00
Financial strength
Current ratio
9.315
Quick ratio
9.092
Long term debt to equity
1.355
Total debt to equity
1.679
Interest coverage (TTM)
-25.00%
Profitability
EBITDA (TTM)
-18.964
Management effectiveness
Return on assets (TTM)
-42.51%
Return on equity (TTM)
-93.23%
Valuation
Price to book
0.51
Price to tangible book (TTM)
0.52
Price to free cash flow (TTM)
-0.402
Free cash flow yield (TTM)
-248.94%
Free cash flow per share (TTM)
-14.949
Growth
Earnings per share change (TTM)
-82.58%
3-year earnings per share growth (CAGR)
-70.82%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for BioVie Inc stock?
BioVie Inc (BIVI) has a market cap of $11M as of August 01, 2025.
What is the P/E ratio for BioVie Inc stock?
The price to earnings (P/E) ratio for BioVie Inc (BIVI) stock is 0 as of August 01, 2025.
Does BioVie Inc stock pay dividends?
No, BioVie Inc (BIVI) stock does not pay dividends to its shareholders as of August 01, 2025.
When is the next BioVie Inc dividend payment date?
BioVie Inc (BIVI) stock does not pay dividends to its shareholders.
What is the beta indicator for BioVie Inc?
BioVie Inc (BIVI) has a beta rating of 1.11. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.